Posted in | News | Nanomaterials

Clinical Tests on Silicon Reveals Antifuse Technology is Scalable

Santa Clara-based Kilopass Technology recently declared that its primary trial chip silicon on TSMC 28nm High-K Metal Gate (HKMG) has revealed that the company’s 2T antifuse technology can be modified to HKMG.

Silicon data reveals that the current 2T bit cell functions well on 28HKMG and can match 22nm and beyond.

Harry Luan, Kilopass chief executive officer says the chip silicon consisted of the multiple 2T bit cell for basic trial and cell modeling. The trial reveals that the technology in HKMG distributes the programming smoothly without impacting its behavior. It displays reduced gate leakage, which leads to an enhanced read margin and high inbound output.

The company’s integrated NVM has been used in standard CMOS removing the need for extra backend procedures. It can be produced in large volumes. It complies with the foundry DFM design regulations and uses devices from the foundry. It does not need extra tolerance or process control.

Source: http://www.kilopass.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 12). Clinical Tests on Silicon Reveals Antifuse Technology is Scalable. AZoNano. Retrieved on November 23, 2024 from https://www.azonano.com/news.aspx?newsID=22173.

  • MLA

    Chai, Cameron. "Clinical Tests on Silicon Reveals Antifuse Technology is Scalable". AZoNano. 23 November 2024. <https://www.azonano.com/news.aspx?newsID=22173>.

  • Chicago

    Chai, Cameron. "Clinical Tests on Silicon Reveals Antifuse Technology is Scalable". AZoNano. https://www.azonano.com/news.aspx?newsID=22173. (accessed November 23, 2024).

  • Harvard

    Chai, Cameron. 2019. Clinical Tests on Silicon Reveals Antifuse Technology is Scalable. AZoNano, viewed 23 November 2024, https://www.azonano.com/news.aspx?newsID=22173.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.